scholarly journals Bortezomib Followed by a Phase I Study of Bortezomib in Combination With High-Dose Melphalan as a Preparative Regimen for Hematopoietic Cell Transplants in Patients With Primary Refractory Multiple Myeloma or Plasma Cell Leukemia

2011 ◽  
Vol 17 (2) ◽  
pp. S200-S201 ◽  
Author(s):  
T. Nishihori ◽  
T.J. Alekshun ◽  
D.M. Sullivan ◽  
M.A. Kharfan-Dabaja ◽  
J. Raychaudhuri ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase I ◽  
Plasma Cell ◽  
Phase I Study ◽  
Hematopoietic Cell ◽  
High Dose ◽  
Cell Leukemia ◽  
Cell Transplants ◽  
Preparative Regimen ◽  
High Dose Melphalan

scholarly journals A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia

2021 ◽  
Vol 11 (3) ◽  
Author(s):  
Chunrui Li ◽  
Wenyue Cao ◽  
Yimei Que ◽  
Qiuxiang Wang ◽  
Yi Xiao ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
T Cell ◽  
Cell Therapy ◽  
Phase I ◽  
Plasma Cell ◽  
Phase I Study ◽  
Cell Leukemia ◽  
T Cell Therapy ◽  
Car T Cell Therapy ◽  
Car T

scholarly journals A Phase I Study Of Clofarabine Plus High Dose Melphalan As A Conditioning Regimen For Allogeneic Transplantation

2010 ◽  
Vol 16 (2) ◽  
pp. S278
Author(s):  
M.H. Kirschbaum ◽  
A.S. Stein ◽  
R. Nakamura ◽  
N. Auayporn ◽  
L. Popplewell ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Conditioning Regimen ◽  
Allogeneic Transplantation ◽  
High Dose ◽  
High Dose Melphalan
Sign in / Sign up

Export Citation Format

Share Document